Tuesday, September 8, 2026

SK Biopharmaceuticals Secures 795 Million USD License for Groundbreaking Epilepsy Drug Opacalim – What You Need to Know

SK Biopharmaceuticals acquires epilepsy drug candidate from Biohaven for 795 million USD, enhancing its global biotech portfolio.

Zendaya and Robert Pattinson Star in The Drama: A Must-See Romance Thriller of 2026

The romantic thriller "The Drama," starring Zendaya and Robert Pattinson, hits South Korea in September, blending romance and suspense.

Unlocking Health: Yuhan Corporation Launches Glucobiotic Probiotic for Diabetes Management in Mexico

Yuhan Corporation launches Glucobiotic in Mexico, targeting diabetes with a probiotic backed by extensive research and local partnerships.

Tag: well-being

North Korea Korea Kim Military AI South Korea market relations development

No posts to display

Top News

Celltrion’s Ramucirumab and Infliximab: The Secrets Behind Their Dominance in Oceania’s...

Jin Joong Hwang - March 10, 2026

Celltrion's cancer and autoimmune products are expanding market share in Australia and New Zealand, enhancing influence in Oceania.

ATEEZ Hits Career High: How GOLDEN HOUR: Part 5 Redefined K-Pop...

July 13, 2026

CGBio’s DCLASSY PDRN receives clinical trial approval from MFDS

April 17, 2026

21 Companies Caught Misleading Consumers with False Health Claims on Haskap...

June 11, 2026

U.S. State Department says official who met Jang Dong-hyuk was aide...

April 24, 2026

Essential Guide to the 2026 Biohealth Supply Chain Stability Project: What...

January 14, 2026

Smoking and Drinking Fuel Oral Cancer Growth, KAIST Study Finds

February 21, 2024

IdeaPad Slim 5 and Yoga Slim 7: Lenovo’s AI Game-Changers

March 24, 2025

- Our Sponsors Ad -

Follow us